Cite
HARVARD Citation
Liberman, J. et al. (2023). Social determinants and distance from certified treatment centers are associated with initiation of esketamine nasal spray among patients with challenging-to-treat major depressive disorder. Medicine. 102 (7), pp. e32895-. [Online].